Kentucky passed a law allowing insurers to encourage patients to try biosimilar medicines before covering the branded equivalent to expand access to lower-cost medicines.
Governor Andy Beshear signed the bill into law last week, joining Arkansas, California and Louisiana in passing similar legislation that aims to remove barriers to biosimilars. Specifically, the law now states that biosimilars, generics and interchangeable biologics can be substituted for a reference product.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.